Centrient Pharmaceuticals

Rotterdam, Netherlands Founded: 1869 • Age: 157 yrs
Active pharmaceutical ingredients and finished dosage forms are manufactured.
Request Access
Report Incorrect Data
Page last updated

About Centrient Pharmaceuticals

Centrient Pharmaceuticals is a Healthcare company based in Rotterdam (Netherlands) founded in 1869. Active pharmaceutical ingredients and finished dosage forms are manufactured. The company has 613 employees. Centrient Pharmaceuticals has completed 1 acquisition, including Astral SteriTech. Its Indian entity Centrient Pharmaceuticals India Private Limited reported revenue of ₹2,240 Cr. Its focus areas include Traditional Pharmaceuticals and Active Pharmaceutical Ingredients.

Company details

Centrient Pharmaceuticals was founded in 1869 and is headquartered in Rotterdam, Netherlands. Operations focus on the pharmaceutical sector, where active pharmaceutical ingredients and finished dosage forms, such as tablets, syrups, and suspensions, are produced. Products encompass antibiotics like beta-lactams including clavulanic acid and amoxicillin, antifungals, and statins. Manufacturing facilities are certified by the FDA.

Operational Areas
Healthcare → Traditional Health & Nutrition
Key Metrics
  • Indian entity revenue
    ₹2,240 Cr

    FY 2025 · +8% YoY

  • Indian entity net profit
    ₹64.76 Cr

    FY 2025 · 3% margin

  • Indian entity EBITDA
    ₹157 Cr

    FY 2025 · 7% margin

  • Employee Count
    613
  • Investments & Acquisitions
    Astral SteriTech

Board of directors of Centrient Pharmaceuticals India Private Limited (Centrient Pharmaceuticals)

Centrient Pharmaceuticals India Private Limited is the primary company behind Centrient Pharmaceuticals. The board of Centrient Pharmaceuticals India Private Limited currently have 3 directors; the longest-serving is Vikram Aditya Sehgal, appointed in 2021. 26 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Vikram Aditya Sehgal
DIN 07550967
CFO04 Jun 20215 yrs 4 moCentrient Pharmaceuticals India Private Limited
Namit Joshi
DIN 02083809
Whole-time director29 Jul 20215 yrs 3 moCentrient Pharmaceuticals India Private Limited
Devesh Prakash Srivastava
DIN 05226431
Whole-time director01 Apr 20233 yrs 7 moCentrient Pharmaceuticals India Private Limited

People of Centrient Pharmaceuticals

117 people are tracked at Centrient Pharmaceuticals (50 in leadership, 67 in team); the tracked headcount is 613.

NameRoleGroup
Atul Mishra
Site Quality HeadLeadership
Roberto Barriga
IT Business PartnerLeadership
Jorge Gil-Martinez
Chief Scientific OfficerLeadership
Leo van Drenth
It-business Partner - Global Finance, Hr, Legal And RA FunctionsLeadership
Mayank Bansal
Head Group Accounting & ReportingLeadership
Patrick Bryson
Head Of HRLeadership
Ramesh Walia
Head Engineering, Maintenance And IERLeadership
Limber Acosta
Director Innovation & Technology DevelopmentLeadership
Nitin Guglani
Head Of Accounting And TreasuryLeadership
Emerson Meneghetti
ESO & FDF QA HeadLeadership
Ricard M.
Internal Control DirectorLeadership
Victor Zamora
Country President & Commercial Director WestLeadership
Ella Groenendijk
HR DirectorLeadership
Michiel Kramer
Global Tax DirectorLeadership
Alexander Krujatz
Chief Commercial Officer (cco)Leadership
Amitabh Yadav
Global Director - Total Rewards, HR Excellence & Country HR Director - NetherlandsLeadership
Gertjan Feenstra
Global Finance Director Quality & Tech OpsLeadership
Vesna Kapelj
Chief Technical OfficerLeadership
Shalabh Goel
Finance Director Global Commercial - API And FDFLeadership
Amit Dixit
Director - QualityLeadership

97 more people are available in the full profile.

Premium access

Complete people profiles for Centrient Pharmaceuticals

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Centrient Pharmaceuticals

Figures of Centrient Pharmaceuticals India Private Limited, the primary company behind Centrient Pharmaceuticals, for FY 2025. Revenue was ₹2,240 Cr (+8% year on year). Net profit was ₹64.76 Cr (3% margin). EBITDA was ₹157 Cr (7% margin). Revenue has grown at a compounded annual rate of +11% over three years and +8% over five years.

  • ₹2,240 CrRevenue · FY 2025 · +8% YoY
  • ₹64.76 CrNet profit · 3% margin
  • ₹157 CrEBITDA · 7% margin
  • ₹160 CrPaid-up capital
  • 613Employees (provident fund records)
  • +11%Revenue CAGR, 3 years
  • +8%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Centrient Pharmaceuticals India Private Limited are on its company page.

Premium access

Detailed financial statements for Centrient Pharmaceuticals

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Centrient Pharmaceuticals

Centrient Pharmaceuticals has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Astral SteriTech.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Astral SteriTech
Regulatory and quality management services are provided to biopharma firms.
astralsteritech.comVadodara, India1991Feb 2021••••
Premium access

Complete acquisition details for Centrient Pharmaceuticals

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Centrient Pharmaceuticals

2 dated milestones of Centrient Pharmaceuticals across 152 years, from founding to its latest funding, stage changes and deals.

  1. Founded Centrient Pharmaceuticals is founded.
  2. Acquisition Acquires Astral SteriTech.

Web traffic of Centrient Pharmaceuticals

The website of Centrient Pharmaceuticals (centrient.com) receives about 2.1K visits a month and ranks #6,610,386 among all websites worldwide, #6,663 in Biotechnology and Pharmaceuticals.

  • Monthly visits
    2.1K

    ▼ 10.7% vs previous month

  • Global rank
    #6,610,386

    among all websites

  • Category rank
    #6,663

    Health · Biotechnology and Pharmaceuticals

Similar websites

Websites whose visitors overlap most with Centrient Pharmaceuticals. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
Centaur Pharmaceuticals
centaurpharma.com
100%
30.6K#1,329,622View details
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Centrient Pharmaceuticals

Centrient Pharmaceuticals was founded in 1869.

Centrient Pharmaceuticals is headquartered in Rotterdam, Netherlands. It is registered at Rotterdam, South Holland, Netherlands.

Centrient Pharmaceuticals has 613 employees.

The primary company behind Centrient Pharmaceuticals, Centrient Pharmaceuticals India Private Limited, reported revenue of ₹2,240 Cr for FY 2025, up 8% year on year.

Centrient Pharmaceuticals was founded in 1869 and is headquartered in Rotterdam, Netherlands. Operations focus on the pharmaceutical sector, where active pharmaceutical ingredients and finished dosage forms, such as tablets, syrups, and suspensions, are produced. Products encompass antibiotics like beta-lactams including clavulanic acid and amoxicillin, antifungals, and statins. Manufacturing facilities are certified by the FDA.

Centrient Pharmaceuticals has made 1 acquisition, including Astral SteriTech.

Centrient Pharmaceuticals operates through Centrient Pharmaceuticals India Private Limited.

The legal entities of Centrient Pharmaceuticals currently have 4 directors, including Vikram Aditya Sehgal, Namit Joshi, Sumit Agarwal and others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available